Conceptual issues in understanding comorbidity in ADHD

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

Why does comorbidity matter? Chapters 1–5 have laid out the clinical description of attention-deficit hyperactivity disorder (ADHD), its epidemiology, and functional impairments. It is well established that in a given sample of patients with ADHD, only about 50–60% of the individuals will be free of any other psychiatric disorder, while the remainder will have one or more psychiatric or learning disorders concurrent with their ADHD [1]. From a clinical perspective, these additional disorders often demand concurrent treatment as they may cause more impairment than the ADHD itself; furthermore the presence of comorbidity complicates studies of the life course and etiology of ADHD. Recently, it has been recognized that “reverse comorbidity” is a reality, that is, patients with “primary” diagnosis of another major psychiatric disorder such as affective disorder or autism spectrum disorder (ASD) also meet criteria for ADHD at rates much higher than in the general population. The term “reverse comorbidity” largely reflects the fact that the comorbidity was first recognized and studied in those with ADHD [2] – but its importance is now recognized for all psychiatric disorders; and that excess overlap of ADHD exists in certain other psychiatric disorders. The usual paradigm in comorbidity research involves comparing at least three groups: those with ADHD alone, those with ADHD who meet criteria for a comorbid disorder (CM), and a sample of controls; ideally a group of patients who have the CM without ADHD should be studied as well, although few studies do this. The psychiatric diagnosis is made via a structured interview according to DSM-IV criteria and groups are examined for differences on a number of variables. First, care must be taken to rule out artificial comorbidity due to the fact that the DSM criteria for ADHD and some disorders share individual criteria items – for instance poor concentration is a symptom of both ADHD and depressive disorders, while increased activity is common to ADHD and mania. However, most children with comorbidity continue to meet criteria for both disorders even when the overlapping symptoms are subtracted out [3, 4]. Second, while epidemiological studies generally show lower levels of comorbidity than clinical samples, meta-analyses of epidemiological studies clearly show that comorbidity is not purely an artifact of referral bias [5]. Jensen et al. have discussed ways in which the CM associated with ADHD is important to study [6].

Original languageEnglish (US)
Title of host publicationAttention-Deficit Hyperactivity Disorder in Adults and Children
PublisherCambridge University Press
Pages63-71
Number of pages9
ISBN (Print)9781139035491, 9780521113984
DOIs
StatePublished - Jan 1 2015

Fingerprint

Attention Deficit Disorder with Hyperactivity
Comorbidity
Psychiatry
Epidemiologic Studies
Personal Autonomy
Learning Disorders
Depressive Disorder
Mood Disorders
Bipolar Disorder
Mental Disorders
Diagnostic and Statistical Manual of Mental Disorders
Artifacts
Meta-Analysis
Epidemiology
Referral and Consultation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pliszka, S. R. (2015). Conceptual issues in understanding comorbidity in ADHD. In Attention-Deficit Hyperactivity Disorder in Adults and Children (pp. 63-71). Cambridge University Press. https://doi.org/10.1017/CBO9781139035491.007

Conceptual issues in understanding comorbidity in ADHD. / Pliszka, Steven R.

Attention-Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press, 2015. p. 63-71.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pliszka, SR 2015, Conceptual issues in understanding comorbidity in ADHD. in Attention-Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press, pp. 63-71. https://doi.org/10.1017/CBO9781139035491.007
Pliszka SR. Conceptual issues in understanding comorbidity in ADHD. In Attention-Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press. 2015. p. 63-71 https://doi.org/10.1017/CBO9781139035491.007
Pliszka, Steven R. / Conceptual issues in understanding comorbidity in ADHD. Attention-Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press, 2015. pp. 63-71
@inbook{fd95c4e3f32345d6bfdbb16394641cb5,
title = "Conceptual issues in understanding comorbidity in ADHD",
abstract = "Why does comorbidity matter? Chapters 1–5 have laid out the clinical description of attention-deficit hyperactivity disorder (ADHD), its epidemiology, and functional impairments. It is well established that in a given sample of patients with ADHD, only about 50–60{\%} of the individuals will be free of any other psychiatric disorder, while the remainder will have one or more psychiatric or learning disorders concurrent with their ADHD [1]. From a clinical perspective, these additional disorders often demand concurrent treatment as they may cause more impairment than the ADHD itself; furthermore the presence of comorbidity complicates studies of the life course and etiology of ADHD. Recently, it has been recognized that “reverse comorbidity” is a reality, that is, patients with “primary” diagnosis of another major psychiatric disorder such as affective disorder or autism spectrum disorder (ASD) also meet criteria for ADHD at rates much higher than in the general population. The term “reverse comorbidity” largely reflects the fact that the comorbidity was first recognized and studied in those with ADHD [2] – but its importance is now recognized for all psychiatric disorders; and that excess overlap of ADHD exists in certain other psychiatric disorders. The usual paradigm in comorbidity research involves comparing at least three groups: those with ADHD alone, those with ADHD who meet criteria for a comorbid disorder (CM), and a sample of controls; ideally a group of patients who have the CM without ADHD should be studied as well, although few studies do this. The psychiatric diagnosis is made via a structured interview according to DSM-IV criteria and groups are examined for differences on a number of variables. First, care must be taken to rule out artificial comorbidity due to the fact that the DSM criteria for ADHD and some disorders share individual criteria items – for instance poor concentration is a symptom of both ADHD and depressive disorders, while increased activity is common to ADHD and mania. However, most children with comorbidity continue to meet criteria for both disorders even when the overlapping symptoms are subtracted out [3, 4]. Second, while epidemiological studies generally show lower levels of comorbidity than clinical samples, meta-analyses of epidemiological studies clearly show that comorbidity is not purely an artifact of referral bias [5]. Jensen et al. have discussed ways in which the CM associated with ADHD is important to study [6].",
author = "Pliszka, {Steven R}",
year = "2015",
month = "1",
day = "1",
doi = "10.1017/CBO9781139035491.007",
language = "English (US)",
isbn = "9781139035491",
pages = "63--71",
booktitle = "Attention-Deficit Hyperactivity Disorder in Adults and Children",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Conceptual issues in understanding comorbidity in ADHD

AU - Pliszka, Steven R

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Why does comorbidity matter? Chapters 1–5 have laid out the clinical description of attention-deficit hyperactivity disorder (ADHD), its epidemiology, and functional impairments. It is well established that in a given sample of patients with ADHD, only about 50–60% of the individuals will be free of any other psychiatric disorder, while the remainder will have one or more psychiatric or learning disorders concurrent with their ADHD [1]. From a clinical perspective, these additional disorders often demand concurrent treatment as they may cause more impairment than the ADHD itself; furthermore the presence of comorbidity complicates studies of the life course and etiology of ADHD. Recently, it has been recognized that “reverse comorbidity” is a reality, that is, patients with “primary” diagnosis of another major psychiatric disorder such as affective disorder or autism spectrum disorder (ASD) also meet criteria for ADHD at rates much higher than in the general population. The term “reverse comorbidity” largely reflects the fact that the comorbidity was first recognized and studied in those with ADHD [2] – but its importance is now recognized for all psychiatric disorders; and that excess overlap of ADHD exists in certain other psychiatric disorders. The usual paradigm in comorbidity research involves comparing at least three groups: those with ADHD alone, those with ADHD who meet criteria for a comorbid disorder (CM), and a sample of controls; ideally a group of patients who have the CM without ADHD should be studied as well, although few studies do this. The psychiatric diagnosis is made via a structured interview according to DSM-IV criteria and groups are examined for differences on a number of variables. First, care must be taken to rule out artificial comorbidity due to the fact that the DSM criteria for ADHD and some disorders share individual criteria items – for instance poor concentration is a symptom of both ADHD and depressive disorders, while increased activity is common to ADHD and mania. However, most children with comorbidity continue to meet criteria for both disorders even when the overlapping symptoms are subtracted out [3, 4]. Second, while epidemiological studies generally show lower levels of comorbidity than clinical samples, meta-analyses of epidemiological studies clearly show that comorbidity is not purely an artifact of referral bias [5]. Jensen et al. have discussed ways in which the CM associated with ADHD is important to study [6].

AB - Why does comorbidity matter? Chapters 1–5 have laid out the clinical description of attention-deficit hyperactivity disorder (ADHD), its epidemiology, and functional impairments. It is well established that in a given sample of patients with ADHD, only about 50–60% of the individuals will be free of any other psychiatric disorder, while the remainder will have one or more psychiatric or learning disorders concurrent with their ADHD [1]. From a clinical perspective, these additional disorders often demand concurrent treatment as they may cause more impairment than the ADHD itself; furthermore the presence of comorbidity complicates studies of the life course and etiology of ADHD. Recently, it has been recognized that “reverse comorbidity” is a reality, that is, patients with “primary” diagnosis of another major psychiatric disorder such as affective disorder or autism spectrum disorder (ASD) also meet criteria for ADHD at rates much higher than in the general population. The term “reverse comorbidity” largely reflects the fact that the comorbidity was first recognized and studied in those with ADHD [2] – but its importance is now recognized for all psychiatric disorders; and that excess overlap of ADHD exists in certain other psychiatric disorders. The usual paradigm in comorbidity research involves comparing at least three groups: those with ADHD alone, those with ADHD who meet criteria for a comorbid disorder (CM), and a sample of controls; ideally a group of patients who have the CM without ADHD should be studied as well, although few studies do this. The psychiatric diagnosis is made via a structured interview according to DSM-IV criteria and groups are examined for differences on a number of variables. First, care must be taken to rule out artificial comorbidity due to the fact that the DSM criteria for ADHD and some disorders share individual criteria items – for instance poor concentration is a symptom of both ADHD and depressive disorders, while increased activity is common to ADHD and mania. However, most children with comorbidity continue to meet criteria for both disorders even when the overlapping symptoms are subtracted out [3, 4]. Second, while epidemiological studies generally show lower levels of comorbidity than clinical samples, meta-analyses of epidemiological studies clearly show that comorbidity is not purely an artifact of referral bias [5]. Jensen et al. have discussed ways in which the CM associated with ADHD is important to study [6].

UR - http://www.scopus.com/inward/record.url?scp=84954176420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954176420&partnerID=8YFLogxK

U2 - 10.1017/CBO9781139035491.007

DO - 10.1017/CBO9781139035491.007

M3 - Chapter

SN - 9781139035491

SN - 9780521113984

SP - 63

EP - 71

BT - Attention-Deficit Hyperactivity Disorder in Adults and Children

PB - Cambridge University Press

ER -